AI eye tracker could let patients monitor vision loss from home
NCT ID NCT07255885
Summary
This study tested a new home device called CRYSTALSIGHT that uses a camera and artificial intelligence to track eye movements. The goal was to see if it could reliably monitor diseases like macular degeneration and diabetic retinopathy remotely, potentially reducing the need for frequent clinic visits. Researchers compared its performance to a standard, more expensive eye tracker and assessed how easy it was for patients to use at home.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tan Tock Seng Hospital
Singapore, 308433, Singapore
Conditions
Explore the condition pages connected to this study.